Author: OMN AI

This article was created with the assistance of OMN AI, the AI-powered editorial platform developed by OMN Group. Every article is reviewed, fact-checked, and approved by a human journalist before publication to ensure accuracy and editorial quality. Learn more at https://omngroup.com

Airstrikes and Retaliation Mark Sharp Escalation After months of relative quiet, fighting has erupted again between Pakistan and the Taliban government in Afghanistan, raising fears of a wider conflict. Pakistan launched airstrikes early Friday on Kabul and other locations, describing the operation as a response to Taliban attacks on its border positions the night before. Pakistani Defence Minister Khawaja Asif said Islamabad’s patience had “run out,” while the military announced the start of Operation Ghazab lil Haq (“Righteous Fury”). According to Pakistan, the strikes targeted Taliban military facilities in Kabul and Kandahar and killed more than 100 fighters. Kandahar is…

Read More

Burger King has introduced an AI chatbot for restaurant staff in the United States.The system connects to employee headsets and supports daily operations. The company calls the voice assistant “Patty.”It listens during customer interactions and detects polite service phrases.Managers receive insights into overall service patterns. Burger King says the tool does not score individual workers.It aims to coach teams and improve the guest experience.The system should help managers recognise strong performance. The wider BK Assistant platform automates several tasks.It removes unavailable items from digital menus in real time.It guides staff through recipe steps during food preparation.It can also flag when…

Read More

A once-daily pill helped people with type 2 diabetes lose up to 8% of body weight.Researchers tested the drug orforglipron against oral semaglutide. Orforglipron lowered blood sugar and reduced appetite without fasting before use.Participants also achieved better glucose control than with semaglutide. More than 1,500 adults joined the year-long international study.Those taking orforglipron lost more weight than patients on semaglutide tablets. Gastrointestinal side effects caused higher dropout rates with the new drug.Regulators have not yet approved it. Experts see major potential for easier, cheaper tablet treatments.Long-term safety and cardiovascular effects still require further study.

Read More

De Niro’s Stark Warning Oscar-winning actor Robert De Niro has once again taken aim at Donald Trump, warning that the president “will never leave” office unless Americans take action. Speaking on MS NOW ahead of the State of the Union, De Niro urged voters to remain vigilant, claiming Trump’s recent remarks about election control should not be dismissed as jokes. He also appeared at a counter-event called “State of the Swamp” at the National Press Club, where he told attendees he felt “betrayed” by the direction of the country. De Niro described the current political climate as being dominated by…

Read More

Aston Martin will cut up to 20% of its workforce as it tries to save about £40m. The move could affect roughly 500 employees. The luxury carmaker confirmed the decision after reporting deeper pre-tax losses for 2025. Losses rose to £363.9m from £289.1m the previous year. The company had already reduced 170 roles at the start of 2024. The group said it had reviewed its structure earlier in 2025. It concluded further changes were necessary to support future plans. Chief executive Adrian Hallmark called the cuts an important step toward a leaner business. Aston Martin has struggled since its 2019…

Read More

A Renewed Push for European Dialogue President Emmanuel Macron is set to outline France’s vision for its nuclear deterrent and how it could contribute more broadly to Europe’s security. Speaking from the Île Longue peninsula — home to France’s four nuclear-powered ballistic missile submarines — Macron is expected to stress that any expanded European dimension of France’s deterrence would complement, not replace, the protection offered by the United States. This marks his first major address on nuclear strategy since 2020, when he proposed involving interested European partners in joint exercises. At the time, the idea drew little attention. Now, however,…

Read More

UN Submission Sparks Fresh Row A new maritime filing by Iraq to the United Nations has reignited tensions with Kuwait, reopening sensitive questions over sea borders in the northern Gulf. Baghdad submitted updated coordinates and a map outlining its claimed waters, a move Kuwait says overlaps with territory it considers its own, including the Fasht al-Qaid and Fasht al-Aij shoals. The disagreement highlights the strategic weight of the region’s waterways and offshore resources, long a source of friction between the two neighbours. Regional Support for Kuwait Several Gulf countries swiftly voiced support for Kuwait’s position. Saudi Arabia, United Arab Emirates,…

Read More

US President Donald Trump has introduced a new global tariff set at ten percent. The tariff took effect after the Supreme Court blocked many of his earlier import taxes on Friday. Trump signed an executive order just hours after the ruling to impose the levy from 24 February. He later threatened to raise the tariff to fifteen percent but has not issued an official directive to increase the rate. The White House has not confirmed whether the higher rate will take effect. Emergency Powers and Rising Business Uncertainty The administration applies the levy under Section 122 of the 1974 Trade…

Read More

Supreme Court Ruling Sparks Fresh Uncertainty The European Parliament has suspended progress on the EU-US trade agreement following a US Supreme Court ruling that declared some of Washington’s 2025 tariffs illegal. The decision triggered a sharp response from President Donald Trump, who announced new 15% import duties, further clouding the future of the deal. German MEP Bernd Lange, who chairs the Parliament’s trade committee, said the legal landscape had shifted dramatically. According to him, the combination of the court ruling and the introduction of new tariffs has fundamentally altered the basis on which the agreement was negotiated. Lawmakers are now…

Read More

The UK has delayed a clinical trial on puberty blockers after the medicines regulator demanded a higher minimum age. Officials warned about unknown long-term biological risks and called for stricter safeguards. The Medicines and Healthcare products Regulatory Agency will hold talks with King’s College London next week. The Department of Health and Social Care confirmed that recruitment will not start until they resolve the concerns. The Pathways trial followed a recommendation from the Cass review. That review found weak evidence for the benefits of puberty blockers in young people. Dr Hilary Cass said a controlled trial was the only way…

Read More